These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15008996)

  • 21. Angiotensin II/Angiotensin (1-7) ratio and 24-h blood pressure throughout the menstrual cycle and in women using oral contraceptives.
    Davis GC; Gibson KJ; Casley D; Brown MA
    J Hypertens; 2017 Jun; 35(6):1178-1186. PubMed ID: 28234675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C
    Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between the angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women.
    Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Tsuda M; Nagai N; Ohama K
    J Am Coll Cardiol; 2001 May; 37(6):1529-35. PubMed ID: 11345361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
    Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
    Herlitz H; Palmgren E; Widgren B; Aurell M
    Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Squire IB; MacFayden RJ; Reid JL; Devlin A; Lees KR
    J Cardiovasc Pharmacol; 1996 May; 27(5):657-66. PubMed ID: 8859935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
    Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
    Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estradiol induces discordant angiotensin and blood pressure responses to orthostasis in healthy postmenopausal women.
    Harvey PJ; Morris BL; Miller JA; Floras JS
    Hypertension; 2005 Mar; 45(3):399-405. PubMed ID: 15699442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women.
    Teerlink T; Neele SJ; de Jong S; Netelenbos JC; Stehouwer CD
    Clin Sci (Lond); 2003 Jul; 105(1):67-71. PubMed ID: 12625833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender affects renal vasoconstrictor response to Ang I and Ang II.
    Gandhi SK; Gainer J; King D; Brown NJ
    Hypertension; 1998 Jan; 31(1):90-6. PubMed ID: 9449397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
    De'Oliveira JM; Price DA; Fisher ND; Allan DR; McKnight JA; Williams GH; Hollenberg NK
    Kidney Int; 1997 Sep; 52(3):771-7. PubMed ID: 9291199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
    Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
    Sumino H; Ichikawa S; Takahashi T; Sakamoto H; Goto-Onozato K; Koya S; Kanda T; Nara M; Seki K; Murakami M; Kurabayashi M
    Maturitas; 2006 Feb; 53(3):306-14. PubMed ID: 16040211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum angiotensin-converting enzyme activity correlates positively with plasma angiotensin II: a population-based study of ambulatory blood pressure and the renin-angiotensin system.
    Nyström F; Karlberg BE; Ohman KP
    J Hum Hypertens; 1997 May; 11(5):301-6. PubMed ID: 9205937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hormone replacement therapy on cardiovascular responses in postmenopausal women with and without type 2 diabetes.
    Manwaring P; Phoon S; Diamond T; Howes LG
    Maturitas; 2002 Nov; 43(3):157-64. PubMed ID: 12443833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
    Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA; Derkx FH; van den Meiracker AH
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.